Serotonin and Interleukin 10 Can Influence the Blood and Urine Viscosity in Gestational Diabetes Mellitus and Pregnancy-Specific Urinary Incontinence
-
Published:2023-12-05
Issue:24
Volume:24
Page:17125
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
França Danielle Cristina Honório1ORCID, Honorio-França Adenilda Cristina2ORCID, Silva Kênia Maria Rezende2, Alves Fernanda Cristina Bérgamo1, Bueno Gabriela1, Costa Sarah Maria Barneze1, Cotrim Aron Carlos de Melo2, Barbosa Angélica Mércia Pascon13, França Eduardo Luzía2, Rudge Marilza Vieira Cunha1, The Diamater Study Group 1
Affiliation:
1. Department of Gynecology and Obstetrics, Botucatu Medical School, São Paulo State University, Botucatu 05508-070, SP, Brazil 2. Biological and Health Sciences Institute, Federal University of Mato Grosso, Barra do Garças 78605-091, MT, Brazil 3. Department of Physiotherapy and Occupational Therapy, School of Philosophy and Sciences, São Paulo State University, Marilia 17525-900, SP, Brazil
Abstract
Serotonin and interleukin 10 (IL-10) may play a role in gestational diabetes mellitus. Hyperglycemic environment, the detrusor musculature of the bladder and pelvic floor muscles may become damaged, leading to urination problems and urine viscosity in pregnant women with gestational diabetes mellitus and pregnancy-specific urinary incontinence. Urine and blood samples were collected from pregnant women between 24 and 28 weeks of gestation. The serotonin concentration and cytokine IL-10 levels were evaluated in plasma and urine. In the total blood and urine, the viscosity was evaluated in the presence and absence of exogenous serotonin and IL-10. The plasma serotonin levels decreased, while the urine serotonin levels increased in the normoglycemic incontinent (NG-I), hyperglycemic continent (GDM-C), and hyperglycemic incontinent (GDM-I) groups. The IL-10 in the plasma decreased in the GDM-I group and was higher in the urine in the NG-I and GDM-I groups. The blood viscosity was higher, independently of urinary incontinence, in the GDM groups. The serotonin increased the blood viscosity from women with GDM-C and urine in the NG-I, GDM-C, and GDM-I groups. Blood and urine in the presence of IL-10 showed a similar viscosity in all groups studied. Also, no difference was observed in the viscosity in either the blood or urine when in the presence of serotonin and IL-10. These findings suggest that serotonin and IL-10 have the potential to reduce blood viscosity in pregnant women with gestational diabetes and specific urinary incontinence, maintaining values similar to those in normoglycemic women’s blood.
Funder
FAPESP—Fundação de Amparo à Pesquisa do Estado de São Paulo CNPq—Conselho Nacional de Desenvolvimento Científico e Tecnológico Coordenação de Aperfeiçoamento de Pessoal de Nível Superior FAPESP
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference68 articles.
1. Changes in T-cell phenotype and cytokines profile in maternal blood, cord blood and colostrum of diabetic mothers;Fagundes;J. Matern. Fetal Neonatal Med.,2016 2. Perić, M., Horvatiček, M., Tandl, V., Bečeheli, I., Majali-Martinez, A., Desoye, G., and Štefulj, J. (2023). Glucose, Insulin and Oxygen Modulate Expression of Serotonin-Regulating Genes in Human First-Trimester Trophoblast Cell Line ACH-3P. Biomedicines, 11. 3. França, D.C.H., França, E.L., Sobrevia, L., Barbosa, A.M.P., Honorio-França, A.C., and Rudge, M.V.C. (2023). Integration of nutrigenomics, melatonin, serotonin and inflammatory cytokines in the pathophysiology of pregnancy-specific urinary incontinence in women with gestational diabetes mellitus. Biochim. Biophys. Acta (BBA)—Mol. Basis Dis., 1869. 4. Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior;Haroon;Neuropsychopharmacology,2012 5. Inflammatory Urinary Cytokine Expression and Quality of Life in Patients with Overactive Bladder;Pillalamarri;Female Pelvic. Med. Reconstr. Surg.,2018
|
|